Pasar al contenido principal

ANALISIS DEL TRANSCRIPTOMA MEDIANTE RNA-SEQ EN PACIENTES CON PATOLOGIA NEUROMUSCULAR NO RESUELTA TRAS SECUENCIACION DE EXOMA: OPTIMIZACION DEL ALGORITMO DIAGNOSTICO.

PI18/01585

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Centro realización IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Iruzubieta, Pablo
  • Kapetanovic, Solange
  • Hernández-Laín, Aurelio
  • Jericó-Pascual, Ivonne|||0000-0003-4262-6370
  • Fernández-Torrón, Roberto
  • Maneiro, Miren
  • Marco-Moreno, Pablo|||0000-0002-0302-9031
  • Zelaya-Huerta, M. Victoria
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Calafell, Francesc|||0000-0002-1083-9438
  • Töpf, Ana
  • Straub, Volker|||0000-0001-9046-3540
  • Vallejo-Illarramendi, Ainara
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Background and purpose: Pathogenic variants in the RYR1 gene have been associated with a variety of conditions, ranging from congenital myopathy to adult manifestations. Our aim was to characterize the p.Leu2286Val variant in 17 Basque patients, to accurately determine its correlation with clinical features and to explore the possible founder effect of the variant. Methods: Families harbouring the p.Leu2286 RYR1 variant underwent a detailed clinical evaluation, including muscle magnetic resonance imaging, electromyography and muscle biopsy. Haplotypes were analysed in available patients and their relatives. Results: Individuals carrying the p.Leu2286Val shared a common haplotype, suggesting a founder event in the Basque Country population. The most prevalent features were exertional myalgia, high creatine kinase (CK) levels, cramps and muscle hypertrophy. None of the patients carrying only the p.Leu2286Val showed progression to severe muscle weakness and muscle magnetic resonance imaging showed a heterogeneous muscle involvement. Muscle biopsy revealed non-specific findings in two patients and features associated with central core disease in one patient carrying only the p.Leu2286Val and two patients harbouring an additional RYR1 variant. Three individuals carrying an in trans RYR1 variant presented with an earlier onset and more severe phenotype. Conclusion: Here, it is shown that the dominantly inherited p.Leu2286Val RYR1 founder variant is associated with a milder phenotype of exercise intolerance, myalgia and hyperCKemia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Kapetanovic, Solange
  • Hernández-Laín, Aurelio
  • Estévez-Arias, Berta|||0000-0002-1711-7489
  • Llansó, Laura|||0000-0003-4950-7657
  • Ortez, Carlos
  • Jou, Cristina|||0000-0002-2223-7880
  • Martí-Carrera, Itxaso
  • López-Márquez, Arístides
  • Rodríguez, Maria José
  • González Mera, Laura
  • Nedkova, Velina
  • Fernández-Torrón, Roberto
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
  • Juntas Morales, Raúl|||0000-0003-2205-1741
  • López-de Munain, Adolfo
  • Surralles, Jordi|||0000-0002-4041-7519
  • Nascimento, Andrés
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Objective: Approximately half of patients with hereditary myopathies remain without a definitive genetic diagnosis after DNA next-generation sequencing (NGS). Here, we implemented transcriptome analysis of muscle biopsies as a complementary diagnostic tool for patients with muscle disease but no definitive genetic diagnosis after exome sequencing. Methods: In total, 70 undiagnosed cases with suspected genetic muscular dystrophies or congenital myopathies were included in the study. Muscle RNAseq comprised the analysis of aberrant splicing, aberrant expression, and monoallelic expression. In addition, existing NGS data or variant calling from RNAseq were reanalyzed, and genome sequencing was performed in selected cases. Four aberrant splicing open-source tools were compared and assessed. Results: RNAseq established a diagnosis in 10/70 patients (14.3%) by identifying aberrant transcripts produced by single nucleotide variants (7/10) or copy number variants (3/10). Reanalysis of NGS data allowed the diagnosis in 9/70 individuals (12.9%). Based on this cohort, FRASER was the tool that reported more splicing outlier events per sample while showing the highest accuracy (81.26%). Conclusions: We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features

  • Llansó, Laura|||0000-0003-4950-7657
  • Stevanovski, Igor
  • Morís, Germán|||0000-0001-7608-2194
  • Collet Vidiella, Roger|||0000-0003-1668-1018
  • Segarra Casas, Alba|||0000-0001-5185-5031
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Gallano, Pia|||0000-0001-8104-2197
  • Alvarez, Rodrigo
  • Vesperinas-Castro, Ana|||0000-0003-1919-9382
  • Blanco, Rosa
  • San-Millán, Beatriz
  • Navarro, Carmen|||0000-0003-4445-8585
  • Illa, Isabel|||0000-0002-2186-2684
  • Ravenscroft, Gianina|||0000-0003-3634-211X
  • W. Deveson, Ira
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
Objective: We aim to describe and characterize two unrelated Spanish families suffering from an autosomal dominant autophagic vacuolar myopathy caused by repeat expansions in PLIN4. Methods: We evaluated the clinical phenotype and muscle imaging, and performed a genetic workup that included exome sequencing, muscle RNAseq, and long-read genome sequencing. Muscle pathology was assessed by means of histochemistry, electron microscopy, PLIN4, p62, LC3, and NBR1 immunofluorescence and/or western blotting. Detailed characterization of autophagic vacuoles was performed. Results: Patients presented around the age of 30 with mild proximal weakness followed by prominent distal weakness in lower legs, eventually spreading to other muscle groups. Muscle biopsies showed unique pathological features characterized by numerous rimmed vacuoles that displayed sarcolemmal features and were located beneath the sarcolemma and within the cytoplasm. Ultrastructural studies showed autophagic vacuoles, replications, and loops of the basal lamina and tubulofilamentous sarcoplasmic inclusions. p62 and NBR1 co-localized with PLIN4 at the sarcolemma and vacuoles. LC3 immunoreactivity and other lysosomal markers were increased at the vacuoles. Targeted long-read sequencing of PLIN4 in affected individuals revealed a single expanded allele of 39 × 99 bp repeats in family 1 and of 37 × 99 bp repeats in family 2. Interpretation: We characterize two new families suffering from an autosomal dominant myopathy carrying repeat expansions in PLIN4. Subsarcolemmal p62 expression is a powerful although nonspecific marker of this disease. No correlation between the size of the expansion and clinical severity can be clearly established. PLIN4 expansions should be considered in the diagnosis of autosomal dominant vacuolar myopathies, especially when sarcolemmal features are present.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum, Una nueva mutación en DES se manifiesta como una insuficiencia respiratoria aislada. Expandiendo el espectro clínico

  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Barrachina Esteve, Oriol|||0000-0002-8519-0784
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Viguera-Martinez, Maria Luisa|||0000-0003-1072-9922
  • Luján, Manel|||0000-0001-9033-7712
  • Guitart Feliubadalo, Maria
  • Miguel Martínez, J.
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Gallano, Pia|||0000-0001-8104-2197
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Olivé, M.
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
Background: Desminopathies are a clinically heterogeneous group of myopathies, with common histological findings in muscle biopsy. Clinically, they usually present with distal and/or proximal muscle weakness often associated with cardiomyopathy. We present 8 patients from 3 unrelated families manifesting isolated respiratory insufficiency without skeletal muscle weakness or heart disease, because of a mutation in the DES gene. Methods: Clinical and demographic data were acquired from medical records. Muscle MRI studies were performed in 6 patients. A muscle biopsy study was performed in the index case from each family. Results: Isolated restrictive respiratory dysfunction was observed in all symptomatic patients, with 2 requiring non-invasive ventilation. Three patients were asymptomatic at the time of the study. None of the patients presented skeletal muscle weakness or heart disease, even after 20 years of disease progression. Muscle MRI showed a common pattern with predominant involvement of the semitendinosus muscle. Muscle biopsy showed patches of cytoplasmic inclusions corresponding to desmin aggregates. The genetic study showed heterozygous presence of the p.Arg415Trp mutation in the DES gene in all patients. Conclusions: We present 5 patients carrying a p.Arg415Trp mutation in the DES gene, manifesting as isolated restrictive respiratory insufficiency without associated skeletal muscle weakness or heart disease. These cases represent a new phenotype associated with DES mutations, thus suggesting that desminopathy should be considered in the diagnostic workup of patients presenting isolated respiratory failure., Antecedentes: Las desminopatías son un grupo de miopatías clínicamente heterogéneas, que comparten hallazgos histológicos comunes en la biopsia muscular. Clínicamente, suelen presentarse con una debilidad muscular distal y/o proximal que a menudo se asocia con una miocardiopatía. Presentamos ocho pacientes de tres familias no emparentadas que se manifiestan como una insuficiencia respiratoria aislada sin debilidad musculoesquelética ni cardiopatía asociada como consecuencia de una mutación en el gen DES. Métodos: Los datos clínicos y demográficos se obtuvieron de las historias clínicas. Se realizó estudio de resonancia magnética muscular en seis pacientes. En los casos índices de cada familia se realizó una biopsia muscular. Resultados: Se observó una disfunción respiratoria restrictiva aislada en todos los pacientes sintomáticos, requiriendo VNI en dos de ellos. Tres pacientes estaban asintomáticos en el momento del estudio. Ninguno de los pacientes presentaron debilidad musculoesquelética o cardiopatía, incluso después de 20 anos ˜ de evolución de la enfermedad. La RM muscular mostró un patrón común con afectación predominante del músculo semitendinoso. La biopsia muscular mostró parches de inclusiones citoplasmáticas correspondientes a agregados de desmina. El estudio genético mostró la misma mutación p.Arg415Trp en heterocigocis en el gen DES en todos los pacientes estudiados. Conclusiones: Presentamos cinco pacientes portadores de la mutación p.Arg415Trp en el gen DES que se manifiesta únicamente como una insuficiencia respiratoria restrictiva aislada sin debilidad musculoesquelética asociada ni cardiopatía. Estos casos representan un nuevo fenotipo asociado con mutaciones DES, lo que sugiere que las desminopatías deben ser consideradas en el proceso diagnóstico de los pacientes con una insuficiencia respiratoria aislada.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events

  • Segarra-Casas, Alba
  • Domínguez‐González, Cristina
  • Hernández-Laín, Aurelio
  • Sánchez-Calvin, María Teresa
  • Camacho, Ana
  • Rivas Infante, Eloy
  • Campo-Barasoain, Andrea
  • Madruga, Marcos
  • Ortez, Carlos
  • Natera-de Benito, Daniel
  • Nascimento, Andrés
  • Codina, Anna
  • Rodríguez, Maria Isabel
  • Gallano, Pia
  • González-Quereda, Lidia
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ., [Background] Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing., [Methods] RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the DMD gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients., [Results] We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in DMD caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity., [Conclusion] These findings indicate that mRNA analysis of the DMD gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing., This study was supported by Instituto de Salud Carlos III and FEDER, ‘Una manera de hacer Europa’ (grant number FIS PI18/01585, LG-Q and PG) and the Ministerio de Universidades (grant number FPU20/06692, AS-C)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dystrophinopathy Phenotypes and Modifying Factors in Exon 45-55 Deletion

  • Poyatos-García, Javier|||0000-0003-3117-4743
  • Martí, Pilar|||0000-0002-1022-9314
  • Liquori, Alessandro|||0000-0002-4842-5986
  • Muelas, Nuria|||0000-0002-2349-7481
  • Pitarch, Inmaculada|||0000-0002-3864-7374
  • Martinez-Dolz, Luis|||0000-0001-5145-8191
  • Rodríguez, Benjamin
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Damiá, Maria|||0000-0003-2933-8438
  • Aller, Elena|||0000-0001-7973-5250
  • Selva-Gimenez, Marta|||0000-0003-4084-7356
  • Vilchez, Roger
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Bárcena LLona, Jose Eulalio|||0000-0002-7156-5960
  • Jauregui, Amaia
  • Gamez, Josep|||0000-0003-3127-7486
  • Aladrén, Jesus Angel
  • Fernández, Ariadna
  • Montolio, Marisol|||0000-0001-5494-5737
  • Azorin, Inmaculada
  • Hervas, David|||0000-0003-0635-4961
  • Casasús, Ana
  • Nieto, Marisa
  • Gallano, Pia|||0000-0001-8104-2197
  • Sevilla, Teresa|||0000-0003-4716-2667
  • Vílchez, Juan J.|||0000-0002-0532-2872
Duchenne muscular dystrophy (DMD) exon 45-55 deletion (del45-55) has been postulated as a model that could treat up to 60% of DMD patients, but the associated clinical variability and complications require clarification. We aimed to understand the phenotypes and potential modifying factors of this dystrophinopathy subset. This cross-sectional, multicenter cohort study applied clinical and functional evaluation. Next generation sequencing was employed to identify intronic breakpoints and their impact on the Dp140 promotor, intronic long noncoding RNA, and regulatory splicing sequences. DMD modifiers (SPP1, LTBP4, ACTN3) and concomitant mutations were also assessed. Haplotypes were built using DMD single nucleotide polymorphisms. Dystrophin expression was evaluated via immunostaining, Western blotting, reverse transcription polymerase chain reaction (PCR), and droplet digital PCR in 9 muscle biopsies. The series comprised 57 subjects (23 index) expressing Becker phenotype (28%), isolated cardiopathy (19%), and asymptomatic features (53%). Cognitive impairment occurred in 90% of children. Patients were classified according to 10 distinct index-case breakpoints; 4 of them were recurrent due to founder events. A specific breakpoint (D5) was associated with severity, but no significant effect was appreciated due to the changes in intronic sequences. All biopsies showed dystrophin expression of.